PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure

Completed

Conditions studied: Heart Failure, Congestive

In brief

The purpose of this study is to determine the value of diagnostic data obtained from Medtronic implantable cardioverter defibrillators (ICDs) with cardiac resynchronization therapy (CRT) to evaluate cardiovascular and heart failure related adverse events and health care utilization.

Key facts

Study ID

NCT00279955

Run by

Medtronic Cardiac Rhythm and Heart Failure

People needed

1024

Starts

2004-06-01

Expected to finish

2008-06-01

Last updated by the study team

2012-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who meet the ICD indications
• Patients with Class III or IV heart failure.
• Patients receiving or who received a Medtronic CRT ICD within the previous 3 months.
• Patient must sign and date informed consent, and be 18 years of age or greater.
• Patient must be available for follow up visits, and be willing and able to comply with study protocol.

You may not qualify if…

• Patient with acute myocardial infarction (MI), coronary artery bypass graft surgery (CABG) or percutaneous coronary angioplasty (PTCA)/stent within the last month.
• Patient with a mechanical right heart valve.
• Patient with chronic (permanent) atrial arrhythmias.
• Patient with life expectancy of less than 12 months.
• Patient with status post heart transplant
• Patient undergoing kidney dialysis
• Patients enrolled in a concurrent study that may confound the results of the study.

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Scottsdale, Arizona, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Loma Linda, California, United States
• Study site — San Diego, California, United States
• Study site — Denver, Colorado, United States
• Study site — Guilford, Connecticut, United States
• Study site — Bradenton, Florida, United States
• Study site — Fort Lauderdale, Florida, United States
• Study site — Key Largo, Florida, United States
• Study site — Melbourne, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Palm Beach Gardens, Florida, United States
• Study site — Pensacola, Florida, United States
• Study site — Safety Harbor, Florida, United States
• Study site — Tallahassee, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Winter Park, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Augusta, Georgia, United States
• Study site — Honolulu, Hawaii, United States
• Study site — Evanston, Illinois, United States
• Study site — Maywood, Illinois, United States
• Study site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.